Page 776 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 5

in exacerbations of chronic obstructive pulmonary disease. 146. Walters JA, Gibson PG, Wood-Baker R, et al. Systemic cortico-
Thorax. 1996;51:1048-1050. steroids for acute exacerbations of chronic obstructive pulmo-
130. Nair S, Thomas E, Pearson SB, et al. A randomized controlled nary disease. Cochrane Database Syst Rev. 2009:CD001288.
trial to assess the optimal dose and effect of nebulized albuterol 147. Lindenauer PK, Pekow PS, Lahti MC, et al. Association of
in acute exacerbations of COPD. Chest. 2005;128:48-54. corticosteroid dose and route of administration with risk of
131. Donohue JF, Hanania NA, Ciubotaru RL, et al. Comparison of treatment failure in acute exacerbation of chronic obstructive
levalbuterol and racemic albuterol in hospitalized patients with pulmonary disease. JAMA. 2010;303:2359-2367.
acute asthma or COPD: a 2-week, multicenter, randomized, 148. Wang YM, Zintel T, Vasquez A, et al. Corticosteroid therapy
open-label study. Clin Ther. 2008;30(Spec No):989-1002. and respiratory muscle function in humans. Am Rev Respir Dis.
132. Cazzola M, D'Amato M, Califano C, et al. Formoterol as dry 1991;144:108-112.
powder oral inhalation compared with salbutamol metered- 149. Gunen H, Hacievliyagil SS, Yetkin O, et al. The role of nebulised
dose inhaler in acute exacerbations of chronic obstructive budesonide in the treatment of exacerbations of COPD. Eur
pulmonary disease. Clin Ther. 2002;24:595-604. Respir J. 2007;29:660-667.
133. Cazzola M, Noschese P, De Michele F, et al. Effect of formoterol/ 150. Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized
budesonide combination on arterial blood gases in patients with budesonide and oral prednisolone with placebo in the treat-
acute exacerbation of COPD. Respir Med. 2006;100:212-217. ment of acute exacerbations of chronic obstructive pulmonary
134. Polverino E, Gomez FP, Manrique H, et al. Gas exchange disease: a randomized controlled trial. Am J Respir Crit Care Med.
2002;165:698-703.
response to short-acting beta2-agonists in chronic obstructive
pulmonary disease severe exacerbations. Am J Respir Crit Care 151. Sethi S, Murphy TF. Infection in the pathogenesis and course
Med. 2007;176:350-355. of chronic obstructive pulmonary disease. N Engl J Med.
2008;359:2355-2365.
135. Karpel JP, Pesin J, Greenberg D, et al. A comparison of the
effects of ipratropium bromide and metaproterenol sulfate in 152. Cameron RJ, de Wit D, Welsh TN, et al. Virus infection in exac-
acute exacerbations of COPD. Chest. 1990;98:835-839. erbations of chronic obstructive pulmonary disease requiring
136. Gross NJ, Petty TL, Friedman M, et al. Dose response to ipratro- ventilation. Intensive Care Med. 2006;32:1022-1029.
pium as a nebulized solution in patients with chronic obstruc- 153. Rosell A, Monso E, Soler N, et al. Microbiologic determinants
tive pulmonary disease. A three-center study. Am Rev Respir of exacerbation in chronic obstructive pulmonary disease. Arch
Dis. 1989;139:1188-1191. Intern Med. 2005;165:891-897.
154. Rothberg MB, Pekow PS, Lahti M, et al. Antibiotic therapy
137. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium and treatment failure in patients hospitalized for acute exac-
in chronic obstructive pulmonary disease. N Engl J Med. erbations of chronic obstructive pulmonary disease. JAMA.
2008;359:1543-1554. 2010;303:2035-2042.
138. Levy RD, Nava S, Gibbons L, et al. Aminophylline and 155. Miravitlles M, Espinosa C, Fernandez-Laso E, et al. Relationship
human diaphragm strength in vivo. J Appl Physiol. 1990;68: between bacterial flora in sputum and functional impairment
2591-2596.
in patients with acute exacerbations of COPD. Study Group of
139. Rice KL, Leatherman JW, Duane PG, et al. Aminophylline for Bacterial Infection in COPD. Chest. 1999;116:40-46.
acute exacerbations of chronic obstructive pulmonary disease. 156. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients
A controlled trial. Ann Intern Med. 1987;107:305-309. with 2009 influenza A(H1N1) infection in Canada. JAMA.
140. Nishimura K, Koyama H, Ikeda A, et al. The additive effect of 2009;302:1872-1879.
theophylline on a high-dose combination of inhaled salbutamol 157. Rello J, Rodriguez A, Ibanez P, et al. Intensive care adult patients
and ipratropium bromide in stable COPD. Chest. 1995;107: with severe respiratory failure caused by Influenza A (H1N1)v
718-723. in Spain. Crit Care. 2009;13:R148.
141. Barr RG, Rowe BH, Camargo CA. Methylxanthines for exac- 158. Spruit MA, Gosselink R, Troosters T, et al. Muscle force during
erbations of chronic obstructive pulmonary disease. Cochrane an acute exacerbation in hospitalised patients with COPD and its
Database Syst Rev. 2003:CD002168. relationship with CXCL8 and IGF-I. Thorax. 2003;58:752-756.
142. Bittar G, Friedman HS. The arrhythmogenicity of theophyl- 159. Schols AM, Soeters PB, Mostert R, et al. Physiologic effects of
line. A multivariate analysis of clinical determinants. Chest. nutritional support and anabolic steroids in patients with chronic
1991;99:1415-1420. obstructive pulmonary disease. A placebo-controlled randomized
143. Calverley PM, Rabe KF, Goehring UM, et al. Roflumilast trial. Am J Respir Crit Care Med. 1995;152:1268-1274.
in symptomatic chronic obstructive pulmonary disease: two 160. Sharma S, Arneja A, McLean L, et al. Anabolic steroids in
randomised clinical trials. Lancet. 2009;374:685-694. COPD: a review and preliminary results of a randomized trial.
144. Albert RK, Martin TR, Lewis SW. Controlled clinical trial of Chron Respir Dis. 2008;5:169-176.
methylprednisolone in patients with chronic bronchitis and 161. Yeh SS, DeGuzman B, Kramer T. Reversal of COPD-associated
acute respiratory insufficiency. Ann Intern Med. 1980;92:753- weight loss using the anabolic agent oxandrolone. Chest.
758. 2002;122:421-428.
145. Rubini F, Rampulla C, Nava S. Acute effect of corticosteroids on 162. Creutzberg EC, Wouters EF, Mostert R, et al. A role for
respiratory mechanics in mechanically ventilated patients with anabolic steroids in the rehabilitation of patients with COPD?
chronic airflow obstruction and acute respiratory failure. Am J A double-blind, placebo-controlled, randomized trial. Chest.
Respir Crit Care Med. 1994;149:306-310. 2003;124:1733-1742.

Section04-O-ref.indd 5 1/21/2015 11:23:21 AM